Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Primary Care
For patients with obesity and elevated alk phos who have RA, do you check a fibroscan or serum NASH fibrosure test before starting methotrexate or leflunomide?
Related Questions
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
How do you help patients understand the difference between prolonged morning stiffness and pain?
How do you manage oral ulcers as a side effect from leflunomide?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
Would you re-challenge a patient with Rituximab who responded well in terms of their RA but developed symptomatic tachycardia after their first infusion?
Are there any recommendations for restarting JAKi after a provoked DVT?
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
How do you approach the management of a patient with RA on methotrexate who has gingivitis or or frequent cavities?
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
